Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Impact of early diagnosis on functional disability in rheumatoid arthritis.

Kim D, Choi CB, Lee J, Cho SK, Won S, Bang SY, Cha HS, Choe JY, Chung WT, Hong SJ, Jun JB, Jung YO, Kim J, Kim SK, Kim TH, Kim TJ, Koh E, Lee HS, Lee J, Lee J, Lee SH, Lee SS, Lee SW, Shim SC, Yoo DH, Yoon BY, Sung YK, Bae SC; KORONA investigators.

Korean J Intern Med. 2017 Jul;32(4):738-746. doi: 10.3904/kjim.2015.364. Epub 2016 Sep 13.

2.
3.

Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients.

Radner H, Alasti F, Smolen JS, Aletaha D.

Arthritis Res Ther. 2015 Aug 11;17:203. doi: 10.1186/s13075-015-0719-x.

4.
5.

Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trials.

Ward MM, Guthrie LC, Alba MI.

Ann Rheum Dis. 2015 Sep;74(9):1691-6. doi: 10.1136/annrheumdis-2013-205079. Epub 2014 May 1.

6.

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Boumpas D, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Rainer F, Pavelka K, Chartier M, Poncet C, Rauch C, Bars ML.

BMC Musculoskelet Disord. 2014 Jan 11;15:14. doi: 10.1186/1471-2474-15-14.

7.

Determination and comparison of the smallest detectable change (SDC) and the minimal important change (MIC) of four-shoulder patient-reported outcome measures (PROMs).

van Kampen DA, Willems WJ, van Beers LW, Castelein RM, Scholtes VA, Terwee CB.

J Orthop Surg Res. 2013 Nov 14;8:40. doi: 10.1186/1749-799X-8-40.

8.

Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: which differences are clinically important?

Adamchic I, Tass PA, Langguth B, Hauptmann C, Koller M, Schecklmann M, Zeman F, Landgrebe M.

Health Qual Life Outcomes. 2012 Jul 10;10:79. doi: 10.1186/1477-7525-10-79.

9.
10.

Clinically important improvement in the WOMAC and predictor factors for response to non-specific non-steroidal anti-inflammatory drugs in osteoarthritic patients: a prospective study.

Hmamouchi I, Allali F, Tahiri L, Khazzani H, Mansouri LE, Ali Ou Alla S, Abouqal R, Hajjaj-Hassouni N.

BMC Res Notes. 2012 Jan 23;5:58. doi: 10.1186/1756-0500-5-58.

11.

Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot Study.

Salhi B, Demedts I, Simpelaere A, Decraene S, Vermaelen K, Surmont V, van Meerbeeck JP, Derom E.

Rehabil Res Pract. 2010;2010:481546. doi: 10.1155/2010/481546. Epub 2010 Aug 5.

12.

Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.

Goldbach-Mansky R, Wilson M, Fleischmann R, Olsen N, Silverfield J, Kempf P, Kivitz A, Sherrer Y, Pucino F, Csako G, Costello R, Pham TH, Snyder C, van der Heijde D, Tao X, Wesley R, Lipsky PE.

Ann Intern Med. 2009 Aug 18;151(4):229-40, W49-51.

13.

Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA).

Osterhaus JT, Purcaru O, Richard L.

Arthritis Res Ther. 2009;11(3):R73. doi: 10.1186/ar2702. Epub 2009 May 20.

14.

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.

Daoussis D, Liossis SN, Tsamandas AC, Kalogeropoulou C, Kazantzi A, Sirinian C, Karampetsou M, Yiannopoulos G, Andonopoulos AP.

Rheumatology (Oxford). 2010 Feb;49(2):271-80. doi: 10.1093/rheumatology/kep093. Epub 2009 May 15.

15.

Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis.

Pouchot J, Kherani RB, Brant R, Lacaille D, Lehman AJ, Ensworth S, Kopec J, Esdaile JM, Liang MH.

J Clin Epidemiol. 2008 Jul;61(7):705-13. doi: 10.1016/j.jclinepi.2007.08.016. Epub 2008 Mar 21.

16.

Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997.

Yelin E, Murphy L, Cisternas MG, Foreman AJ, Pasta DJ, Helmick CG.

Arthritis Rheum. 2007 May;56(5):1397-407.

17.

Response to intramuscular methyl prednisolone in inflammatory hand pain: evidence for a targeted clinical, ultrasonographic and therapeutic approach.

Karim Z, Quinn MA, Wakefield RJ, Brown AK, Green MJ, Hensor EM, Conaghan PG, Emery P.

Ann Rheum Dis. 2007 May;66(5):690-2. Epub 2006 Nov 24.

19.

Determination of the clinical importance of study results.

Man-Son-Hing M, Laupacis A, O'Rourke K, Molnar FJ, Mahon J, Chan KB, Wells G.

J Gen Intern Med. 2002 Jun;17(6):469-76. Review.

20.

Clinically important change in quality of life in epilepsy.

Wiebe S, Matijevic S, Eliasziw M, Derry PA.

J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):116-20.

Supplemental Content

Support Center